Expression of CYP2A genes in human liver and extrahepatic tissues

Biochemical Pharmacology

Volumn 57, Issue 12, 1999, Pages 1407-1413

  Koskela, Satu ^a   Hakkola, Jukka ^a   Hukkanen, Janne ^a   Pelkonen, Olavi ^a   Sorri, Martti ^a   Saranen, Antti ^a   Anttila, Sisko ^b   Fernandez Salguero, Pedro ^c   Gonzalez, Frank ^c   Raunio, Hannu ^c  

^a UNIVERSITY OF OULU   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CYP2A; Cytochrome P450 gene expression; Extrahepatic tissues; Liver; Nasal mucosa; Xenobiotic metabolism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIVER; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; DATABASES, FACTUAL; EXPRESSED SEQUENCE TAGS; HUMANS; LIVER; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 0032939647     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00015-5     Document Type: Article

References (41)

1. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily Update on new sequences, gene mapping, accession numbers and nomenclature . Pharmacogenetics. 6:1996;1-42.
2. Chang T.K.H., Waxman D.J. The CYP2A subfamily. Ioannides C. Cytochromes P450. Metabolic and Toxicological Aspects. 1996;99-134 CRC Press, Boca Raton FL.
3. Pelkonen O., Raunio H. Individual expression of carcinogen-metabolizing enzymes cytochrome P4502A . J Occup Environ Med. 37:1995;19-24.
4. Fernandez-Salguero P., Gonzalez F.J. The CYP2A gene subfamily Species differences, regulation, catalytic activities and role in chemical carcinogenesis . Pharmacogenetics. 5:1995;S123-S128.
5. Yamazaki H., Inui Y., Yun C.-H., Guengerich F.P., Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis. 13:1992;1789-1794.
6. Tiano H.F., Hosokawa M., Clulada P.C., Smith P.B., Wang R., Gonzalez F.J., Crespi C.L., Langenbach R. Retroviral-mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl) 1-butanone (NNK). Carcinogenesis. 14:1993;1421-1427.
7. Crespi C.L., Penman B.W., Leakey J.A.E., Arlotto M.P., Stark A., Parkinson A., Turner T., Steimel D.T., Rudo K., Davies R.L., Langenbach R. Human cytochrome P450IIA3 cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1 . Carcinogenesis. 11:1990;1293-1300.
8. Camus A.-M., Geneste O., Honkakoski P., Bereziat J.-C., Henderson C.J., Wolf C.R., Bartsch H., Lang M.A. High variability of nitrosamine metabolism among individuals Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans . Mol Carcinog. 7:1993;268-275.
9. 1. Proc Natl Acad Sci USA. 87:1990;4790-4793.
10. Yun C.-H., Shimada T., Guengerich F.P. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 40:1991;679-685.
11. Salonpää P., Hakkola J., Pasanen M., Pelkonen O., Vähäkangas K., Battula N., Nouso K., Raunio H. Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. Eur J Pharmacol Environ Toxicol Pharmacol. 248:1993;95-102.
12. Duescher R.J., Elfarra A.A. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation Evidence for major roles by cytochromes P450 2A6 and 2E1 . Arch Biochem Biophys. 311:1994;342-349.
13. Yamano S., Tatsuno J., Gonzalez F.J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 29:1990;1322-1329.
14. Miles J.S., McLaren A.W., Forrester L.M., Glancey M.J., Lang M.A., Wolf C.R. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J. 267:1990;365-371.
15. Kharasch E.D., Hankins D.C., Thummel K.E. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology. 82:1995;689-699.
16. Nunoya K.-I., Yokoi T., Kimura K., Kodama T., Funayama M., Inoue K., Nagashima K., Funae Y., Shimada N., Green C., Kamataki T. (+)-Cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes. J Pharmacol Exp Ther. 277:1996;768-774.
17. Nakajima M., Yamamoto T., Nunoya K.-I., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kuroiwa Y. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos. 24:1996;1212-1217.
18. Nakajima M., Yamamoto T., Nunoya K.-I., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther. 277:1996;1010-1015.
19. Pelkonen O., Raunio H., Rautio A., Mäenpää J., Lang M.A. Coumarin 7-hydroxylase Characteristics and regulation in mouse and man . J Irish Coll Phys Surg. 22:1993;24-28.
20. Smith T.J., Stoner G.D., Yang C.S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung microsomes by cytochromes P450, lipoxygenases and hydroperoxidases. Cancer Res. 55:1995;5566-5573.
21. Shimada T., Yamazaki H., Mimura M., Wakamiya N., Ueng Y.-F., Guengerich F.P., Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab Dispos. 24:1996;515-522.
22. Su T., Sheng J.J., Lipinskas T.W., Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab Dispos. 24:1996;884-890.
23. Thornton-Manning J.R., Nikula K.J., Hotchkiss J.A., Avila K.J., Rohrbacher K.D., Ding X., Dahl A.R. Nasal cytochrome P450 2A Identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen . Toxicol Appl Pharmacol. 142:1997;22-30.
24. Fernandez-Salguero P., Hoffman S.M.G., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J., Evans W.E., Idle J.R., Gonzalez F.J. A genetic polymorphism in coumarin 7-hydroxylation Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles . Am J Hum Genet. 57:1995;651-660.
25. Hoffman S.M.G., Fernandez-Salguero P., Gonzalez F.J., Mohrenweiser H.W. Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19. J Mol Evol. 41:1995;894-900.
26. Jin C.-F., Mata M., Fink D.J. Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Meth Appl. 3:1994;252-255.
27. Ding S., Lake B.G., Friedberg T., Wolf C.R. Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem J. 306:1995;161-166.
28. Peng H.-M., Ding X., Coon M.J. Isolation and heterologous expression of cloned cDNAs for two rabbit nasal microsomal proteins, CYP2A10 and CYP2A11, that are related to nasal microsomal cytochrome P450 form a. J Biol Chem. 268:1993;17253-17260.
29. Chen Y., Getchell M.L., Ding X., Getchell T.V. Immunolocalization of two cytochrome P450 isozymes in rat nasal chemosensory tissue. Neuro Report. 3:1992;749-752.
30. Zupko K., Poria Y., Lancet D. Immunolocalization of cytochromes P-450olf1 and P-450olf2 in rat olfactory mucosa. Eur J Biochem. 196:1991;51-58.
31. Bereziat J.-C., Raffalli F., Schmezer P., Frei E., Geneste O., Lang M.A. Cytochrome P450 2A of nasal epithelium Regulation and role in carcinogen metabolism . Mol Carcinog. 14:1995;130-139.
32. Walters E., Buchheit K., Maruniak J.A. Olfactory cytochrome P-450 immunoreactivity in mice is altered by dichlobenil but preserved by metyrapone. Toxicology. 81:1993;113-122.
33. Lazard D., Tal N., Rubinstein M., Khen M., Lancet D., Zupko K. Identification and biochemical analysis of novel olfactory-specific cytochrome P-450IIA and UDP-glucuronosyl transferase. Biochemistry. 29:1990;7433-7440.
34. Longo V., Amato G., Santucci A., Gervasi P.G. Purification and characterization of three constitutive cytochrome P-450 isoforms from bovine olfactory epithelium. Biochem J. 323:1997;65-70.
35. Getchell M.L., Chen Y., Sparks D.L., Ding X., Getchell T.V. Immunohistochemical localization of a cytochrome P-450 isozyme in human nasal mucosa age-related trends . Ann Otol Rhinol Laryngol. 102:1993;368-374.
36. Reed C.J. Drug metabolism in the nasal cavity Relevance to toxicology . Drug Metab Rev. 25:1993;173-205.
37. Kimura S., Kozak C.A., Gonzalez F.J. Identification of a novel P450 expressed in rat lung cDNA cloning and sequence, chromosome mapping, and induction by 3-methylcholanthrene . Biochemistry. 28:1989;3798-3803.
38. Honkakoski P., Mäenpää J., Leikola J., Pasanen M., Juvonen R., Lang M.A., Pelkonen O., Raunio H. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. Pharmacol Toxicol. 72:1993;107-112.
39. Hukkanen J., Hakkola J., Anttila S., Piipari R., Karjalainen A., Pelkonen O., Raunio H. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human broncho-alveolar macrophages and peripheral blood lymphocytes. Mol Carcinog. 20:1997;224-230.
40. Mace K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., Pfeifer A.M.A. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissue. Eur J Cancer. 34:1998;914-920.
41. Raunio H., Pasanen M., Mäenpää J., Hakkola J., Pelkonen O. Expression of extrahepatic cytochrome P450 in humans. Pacifici G.M., Fracchia G.N. Advances in Drug Metabolism in Man. 1995;234-287 European Commission, Office for Official Publications of the European Communities, Luxembourg.